Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.4975
Delayed Data
As of Mar 30
 -0.0015 / -0.30%
Today’s Change
0.40
Today|||52-Week Range
0.73
-11.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization37.6K90.0K39.5K85.0K
 
 
 
 
 
 
Operating ExpensesGross Income-37.6K-90.0K-39.5K-85.0K
 
 
 
 
 
General Expenses12.9M15.6M21.4M28.9M
 
 
 
 
 
Research And Development5.8M8.1M12.9M19.4M
 
 
 
 
 
Total Operating Expenses13.0M15.7M21.5M29.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-15.7M-21.5M-29.0M
 
 
 
 
 
Extraordinary Credit0.0069.6K0.00--
 
 
Extraordinary Charge-410.9K0.00-79.6K-271.0K
 
 
 
 
Other Expenses60.4K-5.0K-1.4K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.3M-15.6M-21.5M-28.7M
 
 
 
 
 
Net Income-13.3M-15.6M-21.5M-28.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.2M47.6M76.6M122.4M
 
 
 
 
 
Shares To Calculate EPS Diluted28.2M47.6M76.6M122.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.33-$0.28-$0.23
 
 
 
 
 
EPS Diluted-$0.47-$0.33-$0.28-$0.23
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account